Seraseq® Solid Tumor CNV Mix

Gene amplifications and deletions, collectively called copy number variations (CNVs), are common in cancer cells and contribute to uncontrolled cell growth, drug sensitivity and resistance. To support clinical labs performing NGS-based tumor profiling of cancer patient samples and help assay developers develop and characterize the performance of their assays, LGCSeraCare has developed a comprehensive solid tumor CNV reference material in mutation mix format.

FEATURES AND BENEFITS

• 12 clinically relevant CNVs associated with solid tumors
• A single reference material carrying gene amplifications at various levels
• Copy numbers quantified using sensitive dPCR assays and blended with the well-characterized GM24385 genomic background
• Validated by a targeted NGS panel
• Manufactured in GMP-compliant, ISO 13485-certified facilities

Documents

• Seraseq Solid Tumor CNV Mix 3 Copies (Product Sheet)
• Seraseq® Solid Tumor CNV Mix, +6 copies (Product Sheet)
• Seraseq Solid Tumor CNV Mix 12 Copies (Product Sheet)
• Seraseq Solid Tumor CNV Mixes (Package Insert)
• Seraseq Solid Tumor CNV Mix Package Insert (Package Insert)
• Technical Spreadsheet for Seraseq FFPE Solid Tumor CNV Reference Material and Seraseq Solid Tumor CNV Mixes (Technical Spreadsheet)
• Seraseq Solid Tumor Mixes Non-Requirement Letter (SDS Non-Requirement Letter)

Ordering Information